Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Anticancer drug   Cytarabine  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Alexan Austria, Chile, Colombia, Egypt, Germany, Hungary, Luxembourg, Netherlands, Republic of South Africa, Russian, Saudi Arabia, Thailand, Turkey, United Arab Emirates
Alexane Iran
Ara Cell Germany, Portugal
Arabine Denmark, Finland, Iceland, Sweden
Aracytin Brazil, Chile, Colombia, Egypt, Greece, Italy
Aracytine Colombia, France, Morocco
Cancyt India
Citab Brazil
Citarabina Argentina, Chile, Colombia, Ecuador, Italy, Mexico, Spain
Cylocide Japan
Cytaban Colombia
Cytaloxan Portugal
Cytarabine Australia, Belgium, Canada, Denmark, Egypt, Finland, Great Britain, Ireland, Malaysia, New Zealand, United Arab Emirates, United States of America
Cytarax Brazil, Mexico
Cytonal Turkey
Cytosafe Great Britain
Cytosar Austria, Belgium, Canada, Croatia, Denmark, Hungary, Iran, Ireland, Luxembourg, Malaysia, Netherlands, Norway, Poland, Portugal, Republic of South Africa, Saudi Arabia, Switzerland, United Arab Emirates, Venezuela
Ifarab Mexico
Laracit Chile, Colombia, Mexico
Medsara Mexico
Novutrax Colombia, Mexico
Oncorab Venezuela
Tabine Ecuador
Udicil Germany
Zuphacit Mexico
Stability in solutions   Injection   Stability in solutions : Cytarabine     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 0,1 & 20 mg/ml 2-8°C Protect from light
28 Day
2255
Manufacturer's stability data
Glass NaCl 0,9% or Glucose 5% 0,144 mg/ml 23°C Protect from light
72 Hour
1501
Level of evidence A
Glass NaCl 0,9% or Glucose 5% 0,144 mg/ml 4°C Protect from light
72 Hour
1501
Level of evidence A
Glass NaCl 0,9% or Glucose 5% 20 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data
Glass Sodium chloride 0,9% 0,1 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data
Glass Sodium chloride 0,9% 1 mg/ml 2-8°C Protect from light
28 Day
4455
Level of evidence A
Glass Sodium chloride 0,9% 1 mg/ml 25°C Protect from light
14 Day
4455
Level of evidence A
Glass Sodium chloride 0,9% 10 mg/ml 2-8°C Protect from light
28 Day
4455
Level of evidence A
Glass Sodium chloride 0,9% 10 mg/ml 25°C Protect from light
5 Day
4455
Level of evidence A
Glass Sodium chloride 0,9% 5 mg/ml 2-8°C Protect from light
28 Day
4455
Level of evidence A
Glass Sodium chloride 0,9% 5 mg/ml 25°C Light
7 Day
739
Joker
Glass Sodium chloride 0,9% 5 mg/ml 25°C Protect from light
8 Day
4455
Level of evidence A
Glass Glucose 5% 0,1 mg/ml 20-25°C With or without light
14 Day
2255
Manufacturer's stability data
Glass Ringer’s lactate solution 5 mg/ml 25°C Light
7 Day
739
Joker
Glass Elliott’s B solution 3 mg/ml 23°C Not specified
48 Hour
31
Joker
Glass Elliott’s B solution 3 mg/ml 4°C Protect from light
48 Hour
31
Joker
Glass Elliott’s B solution 5 mg/ml 25°C Light
7 Day
739
Joker
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,1 & 20 mg/ml 2-8°C Protect from light
28 Day
2255
Manufacturer's stability data
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,144 mg/ml 23°C Protect from light
72 Hour
1501
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,144 mg/ml 4°C Protect from light
72 Hour
1501
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 20 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data
Polyvinyl chloride Sodium chloride 0,9% 0,1 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data
Polyvinyl chloride Glucose 5% 0,1 mg/ml 20-25°C With or without light
14 Day
2255
Manufacturer's stability data
Polyethylene NaCl 0,9% or Glucose 5% 0,1 & 20 mg/ml 2-8°C Protect from light
28 Day
2255
Manufacturer's stability data
Polyethylene NaCl 0,9% or Glucose 5% 0,144 mg/ml 21°C-22°C Not specified
72 Hour
1520
Manufacturer's stability data
Polyethylene NaCl 0,9% or Glucose 5% 0,144 mg/ml 23°C Protect from light
72 Hour
1501
Level of evidence A
Polyethylene NaCl 0,9% or Glucose 5% 0,144 mg/ml 4°C Protect from light
72 Hour
1501
Level of evidence A
Polyethylene NaCl 0,9% or Glucose 5% 0,144 mg/ml 4°C Not specified
72 Hour
1520
Manufacturer's stability data
Polyethylene NaCl 0,9% or Glucose 5% 20 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data
Polyethylene Sodium chloride 0,9% 0,1 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data
Polyethylene Glucose 5% 0,1 mg/ml 20-25°C With or without light
14 Day
2255
Manufacturer's stability data
Polypropylene Glucose 5% 0,157 mg/ml 25°C With or without light
48 Hour
152
Joker
Polypropylene Glucose 5% 0,157 mg/ml 4°C With or without light
48 Hour
152
Joker
Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 1,25 & 25 mg/ml 22°C Protect from light
28 Day
142
Joker
Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 1,25 & 25 mg/ml 25°C Protect from light
28 Day
844
Joker
Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 1,25 & 25 mg/ml 35°C Protect from light
7 Day
142
Joker
Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 1,25 & 25 mg/ml 35°C Protect from light
14 Day
844
Joker
Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 1,25 & 25 mg/ml 4°C Protect from light
28 Day
142
Joker
Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 1,25 & 25 mg/ml 4°C Protect from light
28 Day
844
Joker
Polypropylen Syringe Water for Injection 20 & 50 mg/ml 21°C Protect from light
30 Day
1229
Level of evidence C
Polypropylen Syringe Water for Injection 20 & 50 mg/ml 6°C-9°C Protect from light
30 Day
1229
Level of evidence C
Polypropylen Syringe NaCl 0,9% or Glucose 5% 0,1 & 20 mg/ml 2-8°C Protect from light
28 Day
2255
Manufacturer's stability data
Polypropylen Syringe NaCl 0,9% or Glucose 5% 20 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data
Polypropylen Syringe Sodium chloride 0,9% 0,1 mg/ml 20-25°C With or without light
28 Day
2255
Manufacturer's stability data
Polypropylen Syringe Sodium chloride 0,9% 1 mg/ml 2-8°C Protect from light
28 Day
4455
Level of evidence A
Polypropylen Syringe Sodium chloride 0,9% 1 mg/ml 25°C Protect from light
14 Day
4455
Level of evidence A
Polypropylen Syringe Sodium chloride 0,9% 10 mg/ml 2-8°C Protect from light
28 Day
4455
Level of evidence A
Polypropylen Syringe Sodium chloride 0,9% 10 mg/ml 25°C Protect from light
5 Day
4455
Level of evidence A
Polypropylen Syringe Sodium chloride 0,9% 5 mg/ml 2-8°C Protect from light
28 Day
4455
Level of evidence A
Polypropylen Syringe Sodium chloride 0,9% 5 mg/ml 25°C Protect from light
8 Day
4455
Level of evidence A
Polypropylen Syringe Glucose 5% 0,1 mg/ml 20-25°C With or without light
14 Day
2255
Manufacturer's stability data
Polypropylen Syringe Elliott’s B solution 3 mg/ml 23°C Not specified
48 Hour
31
Joker
Polypropylen Syringe Elliott’s B solution 3 mg/ml 4°C Protect from light
48 Hour
31
Joker
Polypropylen Syringe None 20 & 50 mg/ml -10°C Protect from light
14 Day
850
Level of evidence B
Polypropylen Syringe None 20 & 50 mg/ml 22°C Not specified
14 Day
850
Level of evidence B
Polypropylen Syringe None 20 & 50 mg/ml 8°C Protect from light
14 Day
850
Level of evidence B
  Mentions Légales